Intravenous Ascorbic Acid and Lung Function in Severely Ill COVID-19 Patients
Current evidence suggests that ascorbic acid improves the host’s immune system and, therefore, may play a role in reducing the severity of infectious diseases. Coronavirus disease 2019 (COVID-19) is a potentially life-threatening viral infection that mainly infects the lungs. The objective of this r...
Main Authors: | Sara Sokary, Asma Ouagueni, Vijay Ganji |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/9/865 |
Similar Items
-
Clinical characteristics and outcomes of COVID-19 critically ill patients: in Sohag governorate
by: Hamdy A Mohammadien, et al.
Published: (2022-01-01) -
Utility of the modified nutritional risk in the critically ill score as an outcome predictor in all-cause acute respiratory distress syndrome and acute febrile illness-induced acute respiratory distress syndrome
by: Pratibha Todur, et al.
Published: (2022-01-01) -
Plasma TIMP-1 as a sex-specific biomarker for acute lung injury
by: Sultan Almuntashiri, et al.
Published: (2022-12-01) -
Outcome Comparison of Acute Respiratory Distress Syndrome (ARDS) in Patients with Trauma-Associated and Non-Trauma-Associated ARDS: A Retrospective 11-Year Period Analysis
by: Lilian Jo Engelhardt, et al.
Published: (2022-09-01) -
Temporal evolution of acute respiratory distress syndrome definitions
by: José R. Fioretto, et al.
Published: (2013-11-01)